|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/00 | |
| A61K 48/00 | |||
| C12N 15/88 |
| (11) | Number of the document | 2970940 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14718277.8 |
| Date of filing the European patent application | 2014-03-14 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2018-07-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/028330 |
| Date | 2014-03-14 |
| (87) | Number | WO 2014/152940 |
| Date | 2014-09-25 |
| (30) | Number | Date | Country code |
| 201361784766 P | 2013-03-14 | US |
| (72) |
HEARTLEIN, Michael, US
|
| (73) |
Translate Bio, Inc.,
29 Hartwell Avenue, Lexington, MA 02421,
US
|
| (54) | MRNA THERAPEUTIC COMPOSITIONS AND USE TO TREAT DISEASES AND DISORDERS |
| MRNA THERAPEUTIC COMPOSITIONS AND USE TO TREAT DISEASES AND DISORDERS |